We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

FISH Probes Approved for Targeted Genome Analysis in Cancer
Blog

Oxford Gene Technology (OGT) recently announced that the US Food and Drug Administration (FDA) has granted de novo classification for eight Cytocell Aquarius® Haematology fluorescence in situ hybridisation (FISH) probes for myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML). We spoke with Steve Chatters, Director of Medical Affairs at OGT, to learn more about the application of FISH probes in modern medicine.

Read More

Supporting Drug Discovery with Cell-centered Models of the Immune System
Blog

Many biological processes, specifically the immune system, operate at a cellular level. CytoReason have harnessed this knowledge to build computational, high-resolution, mechanistic models for a range of diseases that enables better discovery and validation of drug targets.

Read More

Antibody Cascade Design Key to Customizing Success
Blog

We caught up with Abcam's Head of Custom Services, Jamie Campbell, who recently presented at the Protein & Antibody Engineering Summit, Europe. Jamie discusses the company’s approach to discovering antibodies – key reagents in drug discovery, in vitro diagnostics and therapeutics.

Read More

Identifying a Microbial Needle in a Sample Haystack
Blog

We spoke to Dr Jack Regan, CEO of LexaGene, a biotechnology company developing a fully automated pathogen detection platform, and inventor of their patented microfluidic system, about the foundations and evolution of the system, and the future outlook for the tool.

Read More

Deciphering RNA to Predict if a Patient Will Respond to a Targeted Drug
Blog

We recently spoke to Alif Saleh, CEO of Scipher Medicine to learn how RNA data from a patient’s blood sample can be used to determine the underlying molecular processes driving a disease, and establish how well a patient will respond to a particular therapy.

Read More

Genomics Assures Customers About the Source of Their Meat
Blog

How can meat processors and retailers assure their customers that the meat they are buying is what is declared on the packaging? A genetic fingerprinting system is now on hand to provide definitive, traceable evidence.

Read More

Assembling the Pieces of the Genomic Puzzle
Blog

OmniTier Inc.’s new bioinformatics platform, CompStorTM Novos, takes a de novo assembly-based variant calling approach to the challenge of whole genome sequencing. We caught up with Jon Coker, Omnitier’s CTO, to discuss how this approach matches up to rival techniques, and how high-performance computing approaches like Omnitier’s hope to bring personalized medicine a step closer and boost biology in coming years.

Read More

Immunotherapy Response Prediction in Urothelial Cancer
Blog

While immunotherapy holds great promise for cancer treatment, challenges persist around limited response rate and severe immune-related adverse events. We caught up with Dr. Georg Lautscham, CEO of Protagen, to find out how the prediction of immunotherapy response can be improved for people with urothelial cancer.

Read More

Accelerating the Development of Liver Gene Medicines
Blog

Recent technology advancements have enabled the opportunity to increase the efficiency, efficacy and safety of gene and cell-based medicines for a multitude of genetic disorders. To date, a major challenge facing the field has been the ability to deliver therapeutic genes to affected cell types. In this blog, Sarah Haecker Meeks and Michael Roberts from Synpromics outline the ways in which gene medicines can be optimized to overcome this barrier.

Read More

Sustainability Through Innovation
Blog

With growing pressure on labs to reduce waste and improve sustainability, we spoke to the Sustainability Forum at Agilent to learn more about what the company are doing to help their customers achieve their sustainability goals.

Read More